Centessa Pharmaceuticals

CNTA

40.5000.00% ( 0.000 )

Delisted: Jun 26, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Overview: Centessa Pharmaceuticals(CNTA) the EBIT is -79.77 M (-159.2%);the EPS is -0.516 (-162.7%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

EBIT

-0.08B159.20%

----

----

EPS

-0.5161162.69%

----

----

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly